In vitro antimicrobial activity of imipenem plus amikacin or polymyxin B against carbapenem-resistant Pseudomonas aeruginosa isolates-Reference-Cited by-同舟云学术

In vitro antimicrobial activity of imipenem plus amikacin or polymyxin B against carbapenem-resistant Pseudomonas aeruginosa isolates

Published:2018-10 Issue:2 Volume:92 Page:152-154
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

Wilhelm Camila M.,Nunes Luciana de S.,Martins Andreza F.,Barth Afonso L.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference35 articles.

1. Clinically relevant plasma concentrations of Colistin in combination with imipenem enhance Pharmacodynamic activity against multidrug-resistant Pseudomonas aeruginosa at multiple Inocula;Bergen;Antimicrob Agents Chemother,2011

2. Synergistic killing of multidrug-resistant Pseudomonas aeruginosa at multiple Inocula by Colistin combined with Doripenem in an in vitro pharmacokinetic/Pharmacodynamic model;Bergen;Antimicrob Agents Chemother,2011

3. Multidrug-resistant Pseudomonas aeruginosa in Brooklyn, New York: molecular epidemiology and in vitro activity of polymyxin B;Bratu;Eur J Clin Microbiol Infect Dis,2005

4. Synergism of the combinations of imipenem plus ciprofloxacin and imipenem plus amikacin against Pseudomonas aeruginosa and other bacterial pathogens;Bustamante;Antimicrob Agents Chemother,1987

5. Evaluating polymyxin B-based combinations against carbapenem-resistant Escherichia coli in time-kill studies and in a hollow-fiber infection model;Cai;Antimicrob Agents Chemother,2016

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carbapenem-resistant Gram-negative bacteria (CR-GNB) in ICUs: resistance genes, therapeutics, and prevention – a comprehensive review;Frontiers in Public Health;2024-03-27

2. Age of Antibiotic Resistance in MDR/XDR Clinical Pathogen of Pseudomonas aeruginosa;Pharmaceuticals;2023-08-30

3. Evaluation of Aztreonam and Ceftazidime/Avibactam Synergism against Klebsiella pneumoniae by MALDI-TOF MS;Antibiotics;2023-06-16

4. Antibacterial and synergistic activity of a new 8-hydroxyquinoline derivative against methicillin-resistant Staphylococcus aureus;Future Microbiology;2022-04

5. A Retrospective Analysis of Polymyxin B Combined with Tigecycline in the Treatment of Multi-Drug Resistance Klebsiella pneumoniae Infection: Hypertension Increases the Incidence of Acute Kidney Injury;Indian Journal of Pharmaceutical Sciences;2022